Ocean Biomedical Inc OCEA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OCEA is a good fit for your portfolio.
News
-
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
-
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
-
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL
-
Thinking about buying stock in Marathon Digital, Assertio, Ocean Biomedical, Terns Pharmaceuticals, or NextCure?
-
Thinking about buying stock in Ocean Biomedical, Rush Street Interactive, Vivani Medical, Abeona Therapeutics, or Honest Company?
-
Thinking about buying stock in Ocean Biomedical, CASI Pharmaceuticals, Cardiol Therapeutics, Geron, or Rocket Pharmaceuticals?
-
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
-
Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting
Trading Information
- Previous Close Price
- $1.60
- Day Range
- $1.62–1.65
- 52-Week Range
- $0.53–12.00
- Bid/Ask
- $1.62 / $1.65
- Market Cap
- $56.48 Mil
- Volume/Avg
- 56,108 / 6.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 9
- Website
- https://www.oceanbiomedical.com
Comparables
Valuation
|
Metric
|
OCEA
|
SLRN
|
PMVP
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | — | 0.71 | 0.53 |
Price/Sales | — | — | — |
Price/Cash Flow | — | — | — |
Price/Earnings
OCEA
SLRN
PMVP
Financial Strength
|
Metric
|
OCEA
|
SLRN
|
PMVP
|
|---|---|---|---|
Quick Ratio | 0.00 | 13.08 | 14.47 |
Current Ratio | 0.03 | 13.27 | 14.78 |
Interest Coverage | −72.65 | — | — |
Quick Ratio
OCEA
SLRN
PMVP
Profitability
|
Metric
|
OCEA
|
SLRN
|
PMVP
|
|---|---|---|---|
Return on Assets (Normalized) | −115.82% | −28.15% | −22.30% |
Return on Equity (Normalized) | −822.89% | −35.30% | −24.73% |
Return on Invested Capital (Normalized) | −333.05% | −41.97% | −27.28% |
Return on Assets
OCEA
SLRN
PMVP
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Nlpvlybmz | Wctbs | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Rjljbjhn | Gtdyvf | $115.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Gqspjkdh | Bdycyf | $108.2 Bil | |
MRNA
| Moderna Inc | Lzdxlvs | Shp | $54.0 Bil | |
BNTX
| BioNTech SE ADR | Dcqrfvlw | Vwpl | $21.8 Bil | |
ARGX
| argenx SE ADR | Whzbnvmd | Rpmm | $21.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Lwmhzqqpf | Flblbhn | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Zmffkrhf | Rkdlvh | $14.6 Bil | |
INCY
| Incyte Corp | Wtvmgxch | Dbpwy | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Pjlpxxzy | Wnxtq | $12.3 Bil |